SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001493152-23-041652
Filing Date
2023-11-16
Accepted
2023-11-16 15:10:32
Documents
30
Period of Report
2023-11-16
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 42346
2 ex99-1.htm EX-99.1 13632
3 ex99-1_001.jpg GRAPHIC 212904
4 ex99-1_002.jpg GRAPHIC 383803
5 ex99-1_003.jpg GRAPHIC 221785
6 ex99-1_004.jpg GRAPHIC 472903
7 ex99-1_005.jpg GRAPHIC 419790
8 ex99-1_006.jpg GRAPHIC 201522
9 ex99-1_007.jpg GRAPHIC 160933
10 ex99-1_008.jpg GRAPHIC 388061
11 ex99-1_009.jpg GRAPHIC 335566
12 ex99-1_010.jpg GRAPHIC 357251
13 ex99-1_011.jpg GRAPHIC 194588
14 ex99-1_012.jpg GRAPHIC 415472
15 ex99-1_013.jpg GRAPHIC 302130
16 ex99-1_014.jpg GRAPHIC 260517
17 ex99-1_015.jpg GRAPHIC 386650
18 ex99-1_016.jpg GRAPHIC 429740
19 ex99-1_017.jpg GRAPHIC 472961
  Complete submission text file 0001493152-23-041652.txt   7967908

Data Files

Seq Description Document Type Size
20 XBRL SCHEMA FILE pcsa-20231116.xsd EX-101.SCH 3060
21 XBRL LABEL FILE pcsa-20231116_lab.xml EX-101.LAB 34240
22 XBRL PRESENTATION FILE pcsa-20231116_pre.xml EX-101.PRE 22389
24 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3321
Mailing Address 7380 COCA COLA DRIVE SUITE 106 HANOVER MD 21076
Business Address 7380 COCA COLA DRIVE SUITE 106 HANOVER MD 21076 443-776-3133
Processa Pharmaceuticals, Inc. (Filer) CIK: 0001533743 (see all company filings)

IRS No.: 451539785 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39531 | Film No.: 231414292
SIC: 2834 Pharmaceutical Preparations